Nyxoah SA Files Routine 6-K Report
Ticker: NYXH · Form: 6-K · Filed: Nov 20, 2024 · CIK: 1857190
| Field | Detail |
|---|---|
| Company | Nyxoah SA (NYXH) |
| Form Type | 6-K |
| Filed Date | Nov 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, reporting
TL;DR
NYXO files routine 6-K, no major news.
AI Summary
Nyxoah SA, a medical device company, filed a Form 6-K on November 20, 2024. The filing is a report of a foreign private issuer and does not contain specific financial details or material events beyond its routine reporting nature.
Why It Matters
This filing indicates Nyxoah SA is fulfilling its regular reporting obligations as a foreign private issuer with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — This filing is a standard procedural report and does not contain new material information that would typically impact risk.
Key Players & Entities
- Nyxoah SA (company) — Registrant
- 001-40552 (company) — SEC File Number
- 20241120 (date) — Filing Date
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the registrant?
The registrant is Nyxoah SA.
What is the SEC file number for Nyxoah SA?
The SEC file number is 001-40552.
On what date was this report filed?
This report was filed on November 20, 2024.
Does this filing indicate submission in paper format?
The filing indicates check boxes for paper submission under Regulation S-T Rule 101(b)(1) and 101(b)(7) but does not confirm submission in paper, only the possibility.
Filing Stats: 446 words · 2 min read · ~1 pages · Grade level 18.6 · Accepted 2024-11-20 16:21:24
Filing Documents
- tm2428872d1_6k.htm (6-K) — 11KB
- tm2428872d1_ex99-1.htm (EX-99.1) — 30KB
- tm2428872d1_ex99-1img001.jpg (GRAPHIC) — 7KB
- 0001104659-24-121029.txt ( ) — 52KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NYXOAH SA Date: November 20, 2024 By: /s/ Olivier Taelman Name: Olivier Taelman Title: Chief Executive Officer